Dysregulation of the mevalonate pathway during SARS-CoV-2 infection: An in silico study.

Juan Luis Gomez Marti, Alan Wells, Adam M Brufsky

Journal of medical virology 2021 Apr

filter terms:

SARS-CoV-2 triggers a dysregulated innate immune system activation. As the mevalonate pathway (MVP) prevents the activation of inflammasomes and cytokine release and regulates endosomal transport, compromised signaling could be associated with the pathobiology of COVID-19. Prior transcriptomic studies of host cells in response to SARS-CoV-2 infection have not reported to date the effects of SARS-CoV-2 on the MVP. In this study, we accessed public data sets to report in silico investigations into gene expression. In addition, we proposed candidate genes that are thought to have a direct association with the pathogenesis of COVID-19, and which may be dependent on signals derived from the MVP. Our results revealed dysregulation of genes involved in the MVP. These results were not found when investigating the gene expression data from host cells infected with H3N2 influenza virus, H1N1 influenza virus, or respiratory syncytial virus. Our manually curated gene set showed significant gene expression variability in A549 cells infected with SARS-CoV-2, as per Blanco-Melo et al. data set (GSE147507). In light of the present findings, SARS-CoV-2 could hijack the MVP, leading to hyperinflammatory responses. Prompt reconstitution of this pathway with available agents should be considered in future studies. © 2020 Wiley Periodicals LLC.

Citation

Juan Luis Gomez Marti, Alan Wells, Adam M Brufsky. Dysregulation of the mevalonate pathway during SARS-CoV-2 infection: An in silico study. Journal of medical virology. 2021 Apr;93(4):2396-2405